Page 101 - Read Online
P. 101

Karademir. Hepatoma Res 2018;4:58  I  http://dx.doi.org/10.20517/2394-5079.2018.40                                              Page 11 of 18


                                     Table 10. Advanced liver cancer prognostic system [48]
                            Parameters             0     1     2    3     4      5
                            Ascites              No          Yes
                            Abdominal pain             No          Yes
                            Weight loss          No          Yes
                            Child-Pugh           A           B                 C
                            ALP (IU/L)           ≤ 200             > 200
                            Total bilirubin (mg/dL)    ≤ 2   2-3         > 3
                            Urea (mmol/L)              ≤ 8.9       > 8.9
                            Portal vein thrombosis     No                Yes
                            Tumor size           ≤ 5 cm            > 5 cm      Diffuse
                            Lung metastasis            No                Yes
                            Alpha-fetoprotein (ng/mL)   ≤ 400            > 400

                         ALPCS: advanced liver cancer prognostic system; ALP: alkaline phosphates; IU: international unit

                            Table 11. Survival for each prognostic group of corresponding ALPCS score
                                 Prognosis          Score           3 month survival
                             Good (0-8)              0-2              > 0.81
                                                     3-6              0.72-0.8
                                                     7-8              0.66-0.69
                             Intermediate (9-15)     9                0.63
                                                     10-12            0.51-0.59
                                                     13-14            0.42-0.47
                                                     15               0.38
                             Poor (16-39)            16               0.33
                                                     17-19            0.21-0.29
                                                     20-22            0.1-0.17
                                                     ≥ 23            < 0.1


                                           Table 12. Taipei Integrated System [63]
                                                                 Scores
                                                      0        1       2        3
                                           3
                            Total tumor volume (cm )  < 50   50-250   250-500  > 500
                            Child-Pugh               A       B        C
                            Alpha-fetoprotein (ng/mL)  ≤ 400  > 400

               addition, considering 11 factors included into the system, calculation of the score is somewhat complicated
               in daily clinical practice.

               Taipei Integrated Score System score
                                                                         [63]
               The Taipei Integrated Score System (TIS) was proposed by Hsu et al.  in 2010. This system is derived from
               the study of a cohort of 2030 HCC patients undergoing different treatment modalities at a single institution in
               Taiwan. The authors included the total tumor volume (TTV) as an indicator of tumor burden and combined
               it with Child-Pugh grade (A, B and C: 0, 1 and 2 points, respectively) and AFP (<400 vs. > 400 ng/mL: 0 vs. 1
                                                                               3
                                                                                         3
                                                                                                    3
               point) [Table 12]. Calculated TTV was categorized into four groups (< 50 cm , 50-250 cm , 250-500 cm  and >
                     3
               500 cm : 0, 1, 2 and 3 points, respectively). The score identified six distinct prognostic groups. TIS shows
               superior prognostic value compared with the four current staging systems (CLIP, BCLC, JIS and Tokyo) for
               the whole cohort, independently of the treatment modality (curative or palliative). However, in a subgroup
               of 936 patients treated with curative intent, TIS failed to CLIP probably related to vascular invasion (a factor
               in the CLIP but not in the TIS) that was observed in 36.7% of the patients. Although the TTV based staging
               system is a useful and reliable system, it has some limitations. First, all tumors are not spherical. Therefore,
               TTV value may not be accurate in cases involving tumors that are infiltrative or numberless. Second, TIS
   96   97   98   99   100   101   102   103   104   105   106